AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

Nature Medicine
G A DonzellaJ P Moore

Abstract

The bicyclam AMD3100 (formula weight 830) blocks HIV-1 entry and membrane fusion via the CXCR4 co-receptor, but not via CCR5. AMD3100 prevents monoclonal antibody 12G5 from binding to CXCR4, but has no effect on binding of monoclonal antibody 2D7 to CCR5. It also inhibits binding of the CXC-chemokine, SDF-1alpha, to CXCR4 and subsequent signal transduction, but does not itself cause signaling and has no effect on RANTES signaling via CCR5. Thus, AMD3100 prevents CXCR4 functioning as both a HIV-1 co-receptor and a CXC-chemokine receptor. Development of small molecule inhibitors of HIV-1 entry is feasible.

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·E De ClercqD Schwartz
May 1, 1994·The Journal of Infectious Diseases·D D Richman, S A Bozzette
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·E De ClercqR Datema
Jan 1, 1996·Journal of Leukocyte Biology·T N WellsA E Proudfoot
Oct 3, 1996·Nature·F Arenzana-SeisdedosM Baggiolini
Nov 1, 1996·Nature Medicine·B A Premack, T J Schall
Feb 17, 1997·The Journal of Experimental Medicine·R I ConnorN R Landau

❮ Previous
Next ❯

Citations

Jun 2, 2000·Biochemical and Biophysical Research Communications·N TakamuneS Shoji
May 25, 2005·Der Urologe. Ausg. A·F Vom DorpA Eisenhardt
Nov 27, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Alessia BachisItalo Mocchetti
Apr 25, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Italo MocchettiValeriya Avdoshina
Feb 15, 2001·Current Infectious Disease Reports·Georgia D. Tomaras, Michael L. Greenberg
Mar 7, 2012·Immunologic Research·Miljana MomcilovićDjordje Miljković
Sep 29, 2011·Neurotoxicity Research·Italo MocchettiValeriya Avdoshina
Jul 24, 2013·Biochemical Pharmacology·Erik De Clercq
May 12, 2001·Il Farmaco·E De Clercq
Jun 27, 2002·Trends in Pharmacological Sciences·Nathaniel R Landau
May 23, 2001·Antiviral Research·C C LaBrancheS M Hammer
Oct 31, 2001·Antiviral Research·Cecilia CabreraJosé A Esté
May 2, 2000·Drug Discovery Today·W S BlairO B Wallace
May 11, 1999·Drug Discovery Today·J Saunders, C M Tarby
Aug 26, 2000·Current Opinion in Chemical Biology·M A Cascieri, M S Springer
Jul 27, 1999·Current Opinion in Chemical Biology·M K Schwarz, T N Wells
Oct 6, 2001·Current Opinion in Microbiology·M D Miller, D J Hazuda
Nov 17, 2001·Current Opinion in Pharmacology·C A Power, A E Proudfoot
Sep 27, 2002·Current Opinion in Pharmacology·Bryan M O'Hara, William C Olson
Dec 5, 2002·Trends in Immunology·Miguel Angel MartínezJosé A Esté
Nov 26, 2010·Journal of Medicinal Chemistry·Aizhi ZhuHyunsuk Shim
Nov 17, 2011·Journal of Medicinal Chemistry·Won-Tak ChoiJing An
May 19, 1998·Nature Medicine·J S Cairns, M P D'Souza
May 3, 2005·Nature Reviews. Cancer·Honami Naora, Denise J Montell
Jul 18, 2002·Nature Reviews. Drug Discovery·Matthias K Schwarz, Timothy N C Wells
Mar 26, 2004·Nature Reviews. Microbiology·Robin J Shattock, John P Moore
Dec 12, 2001·British Journal of Haematology·H HussonA S Freedman
May 30, 2003·The New England Journal of Medicine·J Michael Kilby, Joseph J Eron
Sep 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·George HajishengallisKathy Triantafilou
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sudarshan RajagopalRobert J Lefkowitz
May 9, 2007·The Journal of Experimental Medicine·François Asperti-BoursinEmmanuel Donnadieu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.